Breaking news on depression
Ex Vivo Results From HIV Positive Individuals With And Without Depression published
Fri, 09 May 2008 04:00:00 PDT
Infection with human immunodeficiency virus (HIV), which leads to acquired immunodeficiency syndrome (AIDS), is an epidemic of global concern. According to the most recent estimates, released in November 2007, by the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health Organization (WHO), an estimated 33.2 million worldwide are living with HIV infection currently.
Depression Treatments Reviewed By NeuroInvestment published
Thu, 08 May 2008 03:00:00 PDT
NeuroInvestment announced the release of its May issue, which reviews novel treatments being developed for depression. Even though depression can be argued to be the success story of psychopharmacology, the current array of largely similar monoamine-targeting drugs leave 30% of patients without adequate relief, and incur significantly aversive side effects for the majority.
Study Demonstrates Lexapro(R) Significantly Improves Depression Symptoms In Adolescents published
Thu, 08 May 2008 00:00:00 PDT
Forest Laboratories, Inc. (NYSE: FRX) announced that study results show Lexapro (escitalopram oxalate) significantly improved symptoms of depression as compared to placebo treatment and was well tolerated in adolescents, aged 12-17, with major depressive disorder (MDD), according to phase III data presented at the 2008 Annual Meeting of the American Psychiatric Association.
New Evidence-Based Guidelines For Antidepressants published
Wed, 07 May 2008 05:00:00 PDT
A new revision of clinical guidelines to help doctors manage patients with depression has challenged the rationale behind the UK government's policy of rolling out of cognitive behavioural therapy (CBT) for milder depression.According to a comprehensive review of treatments for depression, there is a lack of evidence for CBT being more helpful than other forms of psychological support in mild depression or for its efficacy in severe depression.
Studies Show Workplace Depression Is Significantly Under-Treated published
Wed, 07 May 2008 04:00:00 PDT
The Journal of Environmental and Occupational Medicine (JOEM) has published a series of new studies that suggest depression in the workplace may be a much bigger problem - with more serious social and economic impacts - than employers realize. The peer-reviewed journal has devoted an entire special-edition, titled "Depression in the Workplace," to the topic, with 15 papers prepared by experts on depression and workplace health.
Aspect Medical Systems Presents Positive Results Of BRITE Major Depression Study At Scientific Conferences published
Wed, 07 May 2008 02:00:00 PDT
Aspect Medical Systems, Inc. (NASDAQ: ASPM) will present study results from the BRITE (Biomarkers for Rapid Identification of Treatment Effectiveness) trial in major depression at the Society of Biological Psychiatry and American Psychiatric Association Annual Meetings in Washington D.C. this week.
Results Of Brodmann Area 25 Deep Brain Stimulation Pilot Study Offer Hope For Patients With Severe Depression published
Wed, 07 May 2008 01:00:00 PDT
St. Jude Medical, Inc. (NYSE:STJ) announced pilot study results from the first multi-center study investigating deep brain stimulation (DBS) of Brodmann Area 25 for major depressive disorder. Results of the study, which were presented at the American Psychiatric Association (APA) meeting in Washington, D.C., found that 6 months after the procedure, 56 percent of the patients experienced at least a 40 percent decrease in depressive symptoms.
News From The Canadian Medical Association Journal published
Tue, 06 May 2008 04:00:00 PDT
1. Selective serotonin reuptake inhibitors confirmed as treatment for depressionIn treating depression, a 6 to 9 month course of selective serotonin reuptake inhibitors following initial recovery after a first episode of depression is confirmed by this study. This systematic review, based on six classic long-term randomized controlled trials, supports current clinical practice guidelines.
Seroquel Evaluation On Improvement In Short And Long-Term Symptoms published
Tue, 06 May 2008 03:00:00 PDT
AstraZeneca (NYSE:AZN) announced new study data on SEROQUEL XR™ (quetiapine fumarate) Extended-Release Tablets (quetiapine XR) for the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD) in adult patients. The results from the studies were presented today at the 161st Annual Meeting of the American Psychiatric Association (APA) in Washington, DC.
Sudden Death Of A Parent Raises Risk Of Depression, Post-Traumatic Stress Disorder For Surviving Children, Pitt Researchers Find published
Tue, 06 May 2008 02:00:00 PDT
The children of parents who die suddenly - whether by suicide, accident or natural causes - are three times more likely to develop depression and are at higher risk for post-traumatic stress disorder (PTSD) than children who don't face such a difficult life event, according to a University of Pittsburgh School of Medicine study published in the current issue of the Archives of Pediatric & Adolescent Medicine, one of the JAMA/Archives journals.
Low Blood Levels Of Vitamin D May Be Associated With Depression In Older Adults published
Tue, 06 May 2008 01:00:00 PDT
Older adults with low blood levels of vitamin D and high blood levels of a hormone secreted by the parathyroid glands may have a higher risk of depression, according to a report in the May issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Depressed People Have High Rates Of Physical Illness published
Mon, 05 May 2008 03:00:00 PDT
People with recurrent depression have high rates of many common physical illnesses, such as gastric ulcer, rhinitis/hay fever, osteoarthritis, thyroid disease, hypertension and asthma, a new study has found. Published in the May 2008 issue of the British Journal of Psychiatry, the study compared 1546 people with recurrent depression with 884 psychiatrically healthy controls in terms of past treatment for 16 different physical disorders.
Heart Failure Patients May Suffer Similarly To Advanced Cancer Patients published
Mon, 05 May 2008 01:00:00 PDT
Heart failure outpatients have similar numbers of symptoms and levels of depression and spiritual well-being as patients with advanced lung and pancreatic cancer, researchers reported at the American Heart Association's 9th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.
Depressed Heart Failure Patients May Benefit From Exercise Plus Psychological Counseling published
Mon, 05 May 2008 01:00:00 PDT
Aerobic exercise combined with cognitive behavioral therapy may improve physical function, reduce depressive symptoms and enhance quality of life in depressed heart failure patients, researchers reported at the American Heart Association's 9th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.
Multiple Sclerosis Activity May Be Affected By Prozac published
Sat, 03 May 2008 00:00:00 PDT
A new study published in the Journal ofNeurology Neurosurgery and Psychiatry finds that Prozac, acommonly prescribed antidepressant, may be an agent in slowingdown the disease process of the relapsing remitting form of multiplesclerosis (MS).Multiple sclerosis is an autoimmune disease where the immune systemattacks the central nervous system. In the relapsing remitting form,new symptoms occur in discrete attacks.
Depression Turns Off The Music In The Mother-Baby Dance published
Wed, 30 Apr 2008 01:00:00 PDT
Your newborn is crying. If it's a cry of pain, you're going to respond more strongly than you would to a cry of hunger - that's the normal pattern. But if you suffer from post-partum depression, the difference between your response to the pain cry and the hunger cry is going to be even greater. And this, says psychologist Alison Fleming, isn't necessarily a good thing. As part of a study funded by the Canadian Institutes of Health Research (CIHR), Dr.
Women & Depression published
Tue, 29 Apr 2008 02:00:00 PDT
The National Alliance on Mental Illness (NAMI) has released a new brochure, Women and Depression, about the many dimensions of major depression in women. It can be downloaded at http://www.nami.org/womendepression. - 1 in 8 women experiences depression in their lifetime; twice the rate as men, regardless of race or ethnic background.
Deep Brain Stimulation May Offer Hope For Select Patients With Treatment Resistant Major Depression published
Tue, 29 Apr 2008 00:00:00 PDT
Researchers from the Cleveland Clinic, Brown University, and Massachusetts General Hospital will present results of a long-term outcome study that builds on previous promising research, which has shown that deep brain stimulation (DBS) is a potentially effective treatment option for people with treatment resistant major depression.The World Health Organization rates major depression as the top cause of disability worldwide.
According To Research From The University Of Navarra, Smokers Have A 41% Higher Risk Of Suffering Depression published
Fri, 25 Apr 2008 03:00:00 PDT
The risk of suffering depression increases 41% in smokers, in comparison with non-smokers. This was the conclusion of a study undertaken with 8,556 participants by scientists of the University of Navarra, in collaboration with the University of Las Palmas de Gran Canaria and the Harvard School of Public Health (USA), and which demonstrates, in a pioneering way, the direct relationship between tobacco use and this disease.The article, whose first author is Prof.
Biovail Receives FDA Approval For Aplenzin (BVF-033) For The Treatment Of Depression published
Fri, 25 Apr 2008 01:00:00 PDT
Biovail Corporation (NYSE: BVF) (TSX: BVF) announced that it has received Approval from the United States Food and Drug Administration (FDA) for its New Drug Application (NDA) for Aplenzin™ (formerly known as BVF-033), a once-daily formulation of bupropion hydrobromide developed by Biovail for the treatment of depression in adults.
Having A Baby Isn't Blissful For All New Mothers published
Thu, 24 Apr 2008 00:00:00 PDT
For many women, the lovely images of life with a new baby don't jive with their reality. Instead of feeling happy, they feel overwhelmed.University of New Hampshire researcher Kathleen Kendall-Tackett says there are a myriad of treatments available to new mothers experiencing postpartum depression. She is the author of a new monograph, "Non-Pharmacological Treatments for Depression in New Mothers" (2008, Hale Publishing).
Depression Research Employs Laser Dissection published
Wed, 23 Apr 2008 03:00:00 PDT
Chinese investigators from Hefei and Dutch researchers in Amsterdam have collaborated using for the first time a combination of new elegant methodology in Depression research. They used postmortem human brain tissue that was donated to the Netherlands Brain Bank for research purposes and investigated a region in the basal part of the brain, the hypothalamus, that is known to be of crucial importance for the development of symptoms of depression.
Social Form Of Bullying Linked To Depression, Anxiety In Adults published
Wed, 23 Apr 2008 02:00:00 PDT
Spreading rumors and gossiping may not cause bruises or black eyes, but the psychological consequences of this social type of bullying could linger into early adulthood, a new University of Florida study shows.
How To Recognize The Signs And Symptoms Of Anxiety And Depressive Illnesses published
Wed, 23 Apr 2008 01:00:00 PDT
Each year more than 40 million Americans will suffer from an anxiety disorder and more than 19 million Americans will suffer with a depressive illness. The most common signs of anxiety and depression include feelings of being down or blue, phobias, uncontrollable worrying, poor concentration, loss of pleasure, sleeping problems, panic attacks, unexplainable aches, pains or headaches, obsessions, rituals and ongoing feelings of nervousness or tension.
St. Jude Medical Awarded U.S. Patent For Neurostimulation Therapy For Depression published
Tue, 22 Apr 2008 03:00:00 PDT
St. Jude Medical, Inc. (NYSE:STJ) announced it has been awarded a patent from the U.S. Patent and Trademark Office for treating depression using neurostimulation therapy in an area of the brain known as Brodmann Area 25. Brodmann Area 25 is a structure within the subcollosal gyrus region of the brain. It is the focus of the St.
)
|
|
